Product Innovation - Agilent Technologies introduces the 8850 Gas Chromatograph (GC) System, a compact single-channel GC that combines the legacy of the 6850 GC with the capabilities of the 8890 GC [1] - The 8850 GC is designed to revolutionize labs across diverse markets including energy, chemicals, food, and pharmaceuticals [1] - The new GC system reduces energy consumption by up to 30% compared to other GCs [1][2] Technological Advancements - The 8850 GC leverages the latest technological advancements, incorporating engineering excellence and the intelligence of Agilent's smart GC portfolio [2] - Integrated instrument intelligence enhances uptime, while remote connectivity features facilitate regular maintenance and troubleshooting [2] - The instrument's small footprint is half the size of the Agilent 8890 GC, maximizing space utilization and operational redundancy [2] Operational Efficiency - The 8850 GC offers shorter heating and cool-down times, increasing lab throughput [2] - The instrument uses up to 30% less power than other GCs, reducing energy costs and helping labs meet sustainability goals [2] - The 8850 GC uses the same touchscreen interface and connectivity as the 8890 GC, minimizing method migration and development efforts [3] Market Impact - The 8850 GC is a powerful addition to Agilent's market-leading portfolio of GC instruments, promising to transform lab operations with its reliability, high performance, and exceptional data quality [3] - The instrument is designed to meet the needs of modern labs, which face the challenge of maximizing analytical capacity with limited bench space while reducing environmental impact [1] Company Overview - Agilent Technologies is a global leader in analytical and clinical laboratory technologies, generating revenue of $6 83 billion in fiscal 2023 and employing approximately 18,000 people worldwide [4] - The company offers a full range of solutions including instruments, software, services, and expertise to address customers' most challenging questions [4]

The market expects Agilent Technologies (A) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended April 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be relea ...

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Agilent Technologies (A) . This company, which is in the Zacks Electronics - Testing Equipment industry, shows potential for another earnings beat.When looking at the last two reports, this scientific instrument maker has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 4.80%, on a ...

Agilent Technologies (A) is set to showcase a slew of new products at Analytica 2024, to be held between Apr 9 and Apr 12.The company will showcase its newly upgraded BioTek Cytation C10 Confocal Imaging Reader, featuring water immersion and confocal spinning-disk technologies for improved image quality, minimized effects on live-cell samples, and enhanced clarity for thicker samples. Agilent will also showcase Advanced Dilution System (ADS 2).Additionally, the Agilent 1290 Infinity II Bio Online LC Solutio ...

Agilent Technologies (A) has announced its plans to introduce new cell analysis, genomics, digital pathology and companion diagnostics solutions to highlight its advancement in cancer research and diagnostics at the American Association for Cancer Research Annual Meeting.This includes Agilent NovoCyte Opteon Spectral Flow Cytometer, a user-friendly, advanced spectral flow cytometry system with multiple marker panels and up to 70 detectors, enhancing cancer research capabilities.Further, the company will als ...

Core Insights - Agilent Technologies has launched the Advanced Dilution System (ADS) 2 to improve auto-dilution adoption and enhance laboratory workflow efficiency [1] - The global analytical instrumentation market is projected to reach $66.3 billion by 2028, with a CAGR of 6% from 2023 to 2028, presenting growth opportunities for Agilent [1] Segment Focus - The new product launch aligns with Agilent's strategy to strengthen its Life Sciences & Applied Markets Group (LSAG) segment [2] - At the HPLC Conference 2023, Agilent showcased its expanded InfinityLab GPC/SEC Solution and other advanced systems, indicating a focus on material characterization [2] - A Memorandum of Understanding was signed with the Sarawak Infectious Disease Centre to provide the 6475 triple quadrupole LC/MS system for research on neglected tropical diseases, enhancing the LSAG segment's clientele [2] Financial Performance - The LSAG segment is expected to positively impact Agilent's financial performance in the near term, despite facing challenges from sluggish capital equipment spending [3] - Agilent's shares have increased by 4.7% year-to-date, underperforming the Zacks Computer & Technology sector's growth of 12.2% [3] - The Zacks Consensus Estimate for Q2 fiscal 2024 total revenues is $1.58 billion, reflecting a year-over-year decline of 7.8%, while earnings are expected to be $1.19 per share, down 6.3% year-over-year [3]

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.One of our most popular services, Zacks Premium offers daily updates of the Zacks Rank and Zacks Industry Rank; full access to the Zacks #1 Rank List; Equity Research reports; and Premium stock screens like the Earnings ESP filter. All are useful tools to find what stocks to buy, what to sell, and what are today's hottest industries.Also ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today that Joycelyn Tan, a Ph.D. student at the Wellcome-MRC Institute of Metabolic Science at the University of Cambridge, UK, has been awarded the 2024 Darlene Solomon Award. The award recognizes and supports promising female scientists working in mass spectrometry. Ms. Tan is a member of the Fazakerley group, which is dedicated to understanding the mechanisms responsible for obesity and related metabolic diseases. Her ...

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.The Zacks Premium service makes this easier. It features daily updates of the Zacks Rank and Zacks Industry Rank; full access to the Zacks #1 Rank List; Equity Research reports; and Premium stock screens like the Earnings ESP filter. All of these can help you quickly identify what stocks to buy, what to sell, and what are today's hottest ...

Agilent Technologies, Inc. (NYSE:A) 44th Annual TD Cowen Health Care Conference March 4, 2024 2:50 PM ET Company Participants Robert McMahon - SVP and CFO Conference Call Participants Daniel Brennan - TD Cowen Daniel Brennan Great. Here to kick off the Agilent session. I'm Dan Brennan, I cover Tools Diagnostics here. Really pleased to be hosting Bob McMahon, Chief Financial Officer of Agilent here at the 44th Annual TD Cowen Healthcare Conference. So, first off, Bob and Parmeet, welcome. Robert McMahon Than ...